Sales and manufacture of unique anti-drone technology increases as potential users witness capabilities
COLUMBUS, Ohio (July 25, 2017)—Each year, federal and defense authorities stage an event to test new technologies designed to counter the burgeoning threat of rogue or nefarious Unmanned Aircraft Systems (UAS).
Battelle was eager to show the capabilities of its anti-drone device and also give a sneak peek of the advanced features of a prototype DroneDefender at the recent exercise at Elgin Air Force Base in Florida.
Battelle’s DroneDefender has piqued the interest of authorities around the world. The technology is restricted to use by federal authorities under a strict permitting process, but sales are taking off with more than 200 units sold to the U.S. Department of Defense, the U.S. Department of Homeland Security and international customers. Wide adoption around the world has resulted in DroneDefender becoming the most prolific UAS defeat solution.
DroneDefender is the first man-portable, accurate and easy-to-use system to provide critical security protection in a world where these commercially available Unmanned Aircraft Systems (UAS) are showing up at important government buildings, large gatherings of people and other sensitive sites.
DroneDefender uses radio control frequency disruption to safely stop drones in the air before they can pose a threat to military or civilian safety. It is an inexpensive, lightweight point-and-shoot system with a demonstrated range of 400 meters. When the DroneDefender takes aim at the drone, most drones revert to one of three pre-programmed protocols: Hover in place, slowly descend and land, or return to its flight origin point. Click here to see a simulation of it in action.
“We know that the threat posed by nefarious UAS is constantly evolving and we have to adapt our technology to meet those new threats,” said Dan Stamm, a Battelle researcher who helped develop it along with fellow scientist Alex Morrow. “We’re eager to get the DroneDefender in the hands of authorized users so that they can keep ahead of the threat,” Morrow said.
Battelle is continually refining the DroneDefender technology to help ensure its continued value in securing U.S. assets. The newest version that is currently in development has added technical capabilities, removed the backpack resulting in a reduced size and weight, has an improved user interface, and is less expensive.
Battelle has a long history of developing tactical equipment for many branches of the military, working closely with operators to develop, build and field critical equipment to help meet mission needs. DroneDefender units are being produced at Battelle’s Advanced Manufacturing facility in Dublin, Ohio.
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.
For more information contact Katy Delaney at (614)424-7208 or at email@example.com or contact T.R. Massey at (614) 424-5544 or at firstname.lastname@example.org
Disclaimer notice: This device has not been authorized as required by the rules of the Federal Communications Commission. This device is not, and may not be, offered for sale or lease, or sold or leased in the United States, other than to the United States government and its agencies, until authorization is obtained. Under current law, the DroneDefender may be used in the United States only by employees of the Federal government and its agencies, and use by others may be illegal. Due to Federal regulations, the highlighted video is a simulation of the Battelle DroneDefender™ system. It has, though, been successfully tested in Federal government-conducted field trials.